Ticker

Publication demonstrates how complementary IVUS and OCT information supports lesion assessment, treatment planning, and stent optimization while helping manage contrast use Publication demonstrates how complementary IVUS and OCT information supports lesion assessment, treatment planning, and stent optimization while helping manage contrast use

- Achieves U.S. FDA 510(k) Clearance for Next-Generation Hybrid IVUS-OCT Imaging System- Wins Multiple Industry Awards Recognizing Innovation and Leadership in Intravascular Imaging- Advances U.S. Commercial Readiness and Launch Financing Initiatives TORONTO, May 28, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a medical device company focused on designing,…

TORONTO, May 11, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, announced today that it has filed a preliminary short form prospectus (the “Preliminary Prospectus”) with the securities…

Recognition Follows FDA 510(k) Clearance of its Next-Generation Hybrid Intravascular Imaging System Recognition Follows FDA 510(k) Clearance of its Next-Generation Hybrid Intravascular Imaging System